Literature DB >> 6626428

High dose metoclopramide-preliminary pharmacokinetic studies.

W D Taylor, D N Bateman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6626428      PMCID: PMC1428004          DOI: 10.1111/j.1365-2125.1983.tb02173.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  The pharmacokinetics of metoclopramide in man with observations in the dog.

Authors:  D N Bateman; C Kahn; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

2.  Single-dose pharmacokinetics of metoclopramide.

Authors:  L M Ross-Lee; M J Eadie; W D Hooper; F Bochner
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  The pharmacokinetics of single doses of metoclopramide in renal failure.

Authors:  D N Bateman; R Gokal; T R Dodd; P G Blain
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

4.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

5.  Intravenous metoclopramide. An effective antiemetic in cancer chemotherapy.

Authors:  S B Strum; J E McDermed; R W Opfell; L P Riech
Journal:  JAMA       Date:  1982-05-21       Impact factor: 56.272

6.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Authors:  R J Gralla; L M Itri; S E Pisko; A E Squillante; D P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245

  6 in total
  10 in total

1.  Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens.

Authors:  H Havsteen; H Nielsen; M Kjaer
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.

Authors:  D Cunningham; M Soukop; N L Gilchrist; G J Forrest; A Hepplestone; I T Calder; C S McArdle; A W Hutcheon; S B Kaye
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-23

3.  Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis.

Authors:  C Ell; J Braun; H J König; S Domschke; W Domschke
Journal:  Klin Wochenschr       Date:  1985-06-18

4.  Pharmacokinetics and efficacy of high-dose metoclopramide given by continuous infusion for the control of cytotoxic drug-induced vomiting.

Authors:  W B Taylor; S J Proctor; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

5.  The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum.

Authors:  D J Kerr; J Graham; R G Blackie; E McGovern; A W Kelman; D Cunningham; S B Kaye
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

6.  A single dose pharmacokinetic study of Gastrobid Continus and Maxolon in the perioperative period.

Authors:  T H Madej; F R Ellis; I Tring
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 7.  Pharmacokinetics of high-dose metoclopramide in cancer patients.

Authors:  E M McGovern; J Grevel; S M Bryson
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of metoclopramide.

Authors:  D N Bateman
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

9.  Examination of the correlation of serum metoclopramide levels with antiemetic efficacy in patients receiving cisplatin.

Authors:  S M Grunberg; J E McDermed; L Bernstein; J L Cohen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

Authors:  M E O'Brien; M H Cullen; C Woodroffe; K Kelly; C Burman; K Palmer; N S Stuart; G R Blackledge; J Sharpe
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.